Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Critical Reviews in Oncology/Hematology|May 22, 2019
Whole-body hyperthermia in combination with systemic therapy in advanced solid malignanciesG Lassche, J Crezee, C M L Van HerpenCritical Reviews in Oncology/Hematology|March 7, 2002
Prognostic and predictive factors of immunotherapy in metastatic renal cell carcinomaC M L van Herpen, P H M De MulderThe Netherlands Journal of Medicine|January 25, 2014
Fatal microscopic pulmonary tumour embolisms in patients with breast cancer: necessary knowledge for future medical practiceM Vlenterie, I M E Desar, C M L van Herpen, et al.International Journal of Oral and Maxillofacial Surgery|December 24, 2003
An adult case of oral infection with Kingella kingaePh A Van Damme, C M L van Herpen, J F G M MeisFrontiers in Immunology|June 19, 2023
Case Report: Imaging immune checkpoint inhibitor-induced yin-yang effects in the brainK F Bol, E Peeters, C M L van Herpen, et al.The Netherlands Journal of Medicine|March 21, 2009
Pylephlebitis after a duodenal ulcer in a patient with metastasised colon carcinoma treated with chemotherapy and bevacizumab: a case reportL Mannaerts, C P Bleeker-Rovers, M Koopman, et al.The Netherlands Journal of Medicine|April 19, 2018
Drug-drug interactions with aprepitant in antiemetic prophylaxis for chemotherapyR Schoffelen, A G Lankheet, C M L van Herpen, et al.Nederlands Tijdschrift Voor Geneeskunde|August 12, 2020
[Salivary gland carcinoma]G Lassche, A C H van Engen-van Grunsven, J Honings, et al.Oral Oncology|January 7, 2022
Case series of docetaxel, trastuzumab, and pertuzumab (DTP) as first line anti-HER2 therapy and ado-trastuzumab emtansine (T-DM1) as second line for recurrent or metastatic HER2-positive salivary duct carcinomaM J M Uijen, G Lassche, A C H van Engen-van Grunsven, et al.British Journal of Cancer|November 4, 2010
A phase I dose-escalation study to evaluate safety and tolerability of sorafenib combined with sirolimus in patients with advanced solid cancerI M E Desar, J N H Timmer-Bonte, D M Burger, et al.Pageof 5